Long-Term Safety of Methylphenidate in Children and Adolescents With ADHD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
Lancet Psychiatry 2023 May 01;10(5)323-333, KKC Man, A Häge, T Banaschewski, SK Inglis, J Buitelaar, S Carucci, M Danckaerts, RW Dittmann, B Falissard, P Garas, C Hollis, K Konrad, H Kovshoff, E Liddle, S McCarthy, A Neubert, P Nagy, E Rosenthal, EJS Sonuga-Barke, A Zuddas, ICK Wong, D CoghillFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.